Skip to main content
Fig. 2 | Arthritis Research & Therapy

Fig. 2

From: Comparison of two different folic acid doses with methotrexate – a randomized controlled trial (FOLVARI Study)

Fig. 2

Change in disease activity (DAS 28(3)) and EULAR response criteria achieved by 24 weeks in the two groups. The p value was not significant at any time point. DAS 28(3) modified disease activity score using three variables, EULAR European League Against Rheumatism, FA10 group in which folic acid 10 mg per week was given, FA30 group in which folic acid 30 mg per week was given

Back to article page